HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy-Reference-Cited by-同舟云学术

HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy

Published:2016-12-08 Issue:2 Volume:13 Page:291-297
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Paolini Francesca¹,Curzio Gianfranca¹,Cordeiro Marcelo Nazario²,Massa Silvia³,Mariani Luciano¹,Pimpinelli Fulvia⁴,de Freitas Antonio Carlos²,Franconi Rosella³,Venuti Aldo¹

Affiliation:

1. Regina Elena National Cancer Institute, HPV Unit, Rome, Italy

2. Federal University of Pernambuco, Department of Genetics, LEMTE, Pernambuco, Brazil

3. ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic Development, C.R. Casaccia, Rome, Italy

4. San Gallicano Dermatologic Institute, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1264777

Reference36 articles.

1. Papillomavirus E5: the smallest oncoprotein with many functions

2. The Human Papillomavirus Type 16 E5-Protein Modulates Ligand-Dependent Activation of the EGF Receptor Family in the Human Epithelial Cell Line HaCaT

3. Human papillomavirus 16 E2 interacts with neuregulin receptor degradation protein 1 affecting ErbB-3 expression in vitro and in clinical samples of cervical lesions

4. The E5 Oncoprotein of Human Papillomavirus Type 16 Enhances Endothelin-1-Induced Keratinocyte Growth

5. Bap31 Is a Novel Target of the Human Papillomavirus E5 Protein

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between human papillomavirus and lung cancer: A Mendelian randomization study;Infection, Genetics and Evolution;2024-09

2. Identification and Functional Implications of the E5 Oncogene Polymorphisms of Human Papillomavirus Type 16;Tropical Medicine and Infectious Disease;2024-06-26

3. Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis;Archives of Biochemistry and Biophysics;2023-09

4. Immunoinformatics applications in the development of therapeutic vaccines against human papillomavirus‐related infections and cervical cancer;Reviews in Medical Virology;2023-06-08

5. Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer;Cancers;2023-03-24